儿童中困难菌感染:流行病学,诊断,治疗的最新更新
Debbie-Ann Shirley1, William Tornel1, Cirle A Warren2,3
1Pediatric Infectious Diseases, Department of Pediatrics.
Pediatrics
|August 10, 2023
概括
儿童中Clostridioides difficile感染 (CDI) 正在增加,通常与社区相关. 新的治疗方法显示出希望,但优化治疗严重或复发的儿科CDI仍然至关重要.
科学领域:
- 儿童传染病 儿童传染病
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 艰难菌感染 (CDI) 是全球抗生素相关腹的重要原因,也是美国领先的医疗相关感染.
- 儿童CDI发病率正在增加,每年有2万例,通常与社区相关,影响教育和经济.
- 儿童的疾病严重程度差异很大,从无症状的携带到严重的,可能致命的结果,诊断因殖民挑战而复杂.
研究的目的:
- 审查了解和管理Clostridioides difficile感染 (CDI) 的最新进展,特别是在儿童群体中.
- 突出新兴的流行病学趋势和儿科CDI的治疗策略.
- 确定优化儿童CDI治疗的未满足需求,特别是严重和复发性病例.
主要方法:
- 关于儿科Clostridioides difficile感染的最近研究的文献综述.
- 对儿科CDI治疗的流行病学数据和临床试验结果的分析.
- 综合当前关于儿童诊断挑战和治疗选择的知识.
主要成果:
- 儿科CDI越来越常见,并且经常是社区获得的,与成人感染不同.
- 目前的诊断方法难以区分儿童的殖民和感染,因此需要新的生物标志物.
- 口服万科米辛和菲达克索米辛正在成为安全有效的治疗方法,便微生物种移植正在为复发性CDI获得吸引力.
结论:
- 虽然新疗法提供了希望,但优化治疗严重和复发的儿科CDI是一个持续的挑战.
- 准确的诊断工具对于儿童CDI的有效管理至关重要.
- 需要进一步的研究来完善儿科Clostridioides difficile感染的治疗策略.
更多相关视频
06:51Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
12.6K
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
10.2K
相关概念视频
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
158
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
158
01:29Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
01:17Drugs for Treatment of Diarrhea-Predominant IBS
213
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
213
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
355
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
355
01:17Transmission-based Precautions I: Contact, Enteric, and Droplets
3.7K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
3.7K
01:22Healthcare Associated Infections II: Preventive Measures
2.7K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.7K